In pharmaceutical research and drug discovery, these compounds are vital for investigating biological pathways and validating therapeutic targets that were historically considered undruggable. Pharmaceutical laboratories rely on high-quality reference standards to support rigorous analytical testing, including impurity profiling and the development of robust, stability-indicating methods. Because these molecules often feature complex structures and linkers, precise identification of process-related impurities and degradation products is essential for method validation and ensuring the safety and quality of these novel therapeutic candidates throughout the development process.